Micrometastatic p53-Positive Cells in the Lymph Nodes of Early Stage Epithelial Ovarian Cancer: Prognostic Significance
- 1 February 2001
- journal article
- Published by S. Karger AG in Oncology
- Vol. 60 (2) , 170-175
- https://doi.org/10.1159/000055315
Abstract
We used immunohistochemical staining of p53 protein to detect micrometastasis in regional lymph nodes that were judged tumor-free by conventional histopathological methods in 58 patients with stage I or II (pT1 or 2, N0) epithelial ovarian cancer. Overexpression of p53 protein in the primary lesions of ovarian cancer was observed in 31 patients (53%), and p53 protein-positive cells were detected in the regional lymph nodes (micrometastasis-positive) in 19 of 31 patients with p53 protein overexpression (61%). In patients with micrometastasis, the prognosis was significantly poorer than that in those without micrometastasis (p < 0.05). Detection of micrometastasis of the regional lymph nodes of ovarian cancer by immunohistochemical staining of p53 protein may be useful in predicting the prognosis of patients with stage I or II epithelial ovarian cancer.Keywords
This publication has 6 references indexed in Scilit:
- Cytokeratin-Positive Cells in the Bone Marrow and Survival of Patients with Stage I, II, or III Breast CancerNew England Journal of Medicine, 2000
- Role of immunohistochemical detection of lymph-node metastases in management of breast cancerThe Lancet, 1999
- Toward the development of a universal grading system for ovarian epithelial carcinomaCancer, 1998
- Detection of disseminated lung cancer cells in lymph nodes: Impact on staging and prognosisThe Annals of Thoracic Surgery, 1996
- Clinical Implications of the p53 Tumor-Suppressor GeneNew England Journal of Medicine, 1993
- An immunochemical analysis of the human nuclear phosphoprotein p53Journal of Immunological Methods, 1992